Aziz Mottiwala
Corporate Officer/Principal chez TARSUS PHARMACEUTICALS, INC.
Fortune : 1 M $ au 30/06/2024
Profil
Aziz Mottiwala is currently a Director at OneOc, Octane Oc, and Tarsus Pharmaceuticals, Inc. He previously worked as Vice President-Marketing Eye Car Portfolio at Allergan, Inc., SVP-Sales & Marketing, Head-Commercial at Avanir Pharmaceuticals, Inc., and Chief Commercial Officer at Opiant Pharmaceuticals, Inc. Mr. Mottiwala completed his undergraduate degree at the University of California San Diego and his MBA at USC Marshall School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/03/2024 | 54 075 ( 0,14% ) | 1 M $ | 30/06/2024 |
Postes actifs de Aziz Mottiwala
| Sociétés | Poste | Début |
|---|---|---|
| TARSUS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2020 |
| OneOc | Directeur/Membre du Conseil | 01/03/2018 |
| Octane Oc | Directeur/Membre du Conseil | 01/05/2021 |
Anciens postes connus de Aziz Mottiwala
| Sociétés | Poste | Fin |
|---|---|---|
| OPIANT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2020 |
| AVANIR PHARMACEUTICALS INC | Sales & Marketing | 01/09/2019 |
| ALLERGAN, INC. | Sales & Marketing | 01/07/2017 |
Formation de Aziz Mottiwala
| University of California San Diego | Undergraduate Degree |
| USC Marshall School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TARSUS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
| OneOc | |
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
| Octane Oc |
